EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Prevalence of function‐limiting late effects in survivors of head and neck cancer

Yu Hui Won iD, Michael D Stubblefield

PM&R · 2025-06 · 17 (6) · 654-662

DOI: 10.1002/pmrj.13340 ↗

Kurz gefasst

Fachartikel in der Zeitschrift PM&R, online erschienen am 26.02.2025. Verfasst von Yu Hui Won und 1 weiteren Autor:innen. Beteiligte Einrichtung: Department of Physical Medicine and Rehabilitation, Jeonbuk National University Medical School, Jeonju, South Korea. Hauptthemen laut MEDLINE: Head and Neck Neoplasms, Quality of Life, Cancer Survivors, Neuromuscular Diseases. Die Arbeit wurde bisher 14-mal zitiert (Crossref) und nennt 45 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Survivors of head and neck cancer (HNC) are commonly affected by multiple complex and interrelated long‐term and late effects that can adversely affect their function and quality of life.

Objective

To define the prevalence of neuromuscular, musculoskeletal, visceral, oncologic, and other late effects affecting function and quality of life in survivors of HNC.

Design

Retrospective cohort analysis.

Setting

Outpatient cancer rehabilitation clinic at a physical medicine and rehabilitation hospital that includes a freestanding inpatient rehabilitation unit along with an outpatient clinic.

Participants

One hundred thirty survivors of HNC who sought specialized cancer rehabilitation services to address complex functional impairments.

Interventions

Not applicable. Main Outcome Measures Prevalence of neuromuscular, musculoskeletal, visceral, oncologic, and other late effects affecting function and quality of life in survivors of HNC.

Results

The majority underwent surgery (53.8%), chemotherapy (22.3%), and radiation therapy (93.8%) as part of their treatment. Neuromuscular complications such as myelopathy (45.4%), radiculoplexopathy (58.5%), mononeuropathy (84.6%), and myopathy (57.7%) were prevalent. Musculoskeletal impairments included dysphagia (92.3%), dysarthria (60.8%), trismus (40.8%), cervical dystonia (47.7%), and shoulder dysfunction (27.7%). Visceral disorders encompassed lymphedema (86.2%), hypothyroidism (26.2%), and baroreceptor failure (19.2%). Additionally, oncologic complications, including recurrence (18.5%), metastasis (5.4%), and secondary malignancies (8.5%) were observed. Pain (74.6%) and fatigue (31.5%) were reported as major function‐limiting impairments. Most survivors (96.9%) were referred to therapy including physical therapy (85.4%), occupational therapy (13.1%), speech‐language pathology (84.6%), and lymphedema therapy (72.3%). Most (85.4%) required two or more therapy disciplines.

Conclusion

Survivors of HNC accessing cancer rehabilitation services commonly present with diverse, complex, and interrelated neuromuscular, musculoskeletal, visceral, and oncologic late effects that can severely affect function and quality of life. Comprehensive rehabilitation should include evaluation and management of these complex and interrelated late effects by a rehabilitation team that includes cancer rehabilitation physicians, physical therapists, occupational therapists, lymphedema therapists, and speech‐language pathologists, among others.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Head and Neck NeoplasmsQuality of LifeCancer SurvivorsNeuromuscular DiseasesMusculoskeletal DiseasesHumansMaleRetrospective StudiesFemaleMiddle AgedPrevalenceAgedAdult

Autor:innen und Institutionen

  • Department of Physical Medicine and Rehabilitation, Jeonbuk National University Medical School, Jeonju, South Korea.
  • Research Institute of Clinical Medicine of Jeonbuk National University, BiomedicalResearch Institute of Jeonbuk National University Hospital, Jeonju, South Korea.
  • Medical Director for Cancer Rehabilitation, Kessler Institute for Rehabilitation, West Orange, New Jersey, USA.
  • Medical Director for Complex Medical Rehabilitation for the Inpatient Rehabilitation Hospital Division, Select Medical, Mechanicsburg, PA, USA.
  • Medical Director for ReVital Cancer Rehabilitation, Select Medical, Mechanicsburg, PA, USA.
  • Department of Physical Medicine and Rehabilitation, Rutgers New Jersey Medical School, Newark, New Jersey, USA.

ORCID-Profile: Yu Hui Won

Zitieren

APA

Won, Y. H., & Stubblefield, M. D. (2025). Prevalence of function‐limiting late effects in survivors of head and neck cancer. PM&R, 17(6), 654-662. https://doi.org/10.1002/pmrj.13340

Vancouver

Won YH, Stubblefield MD. Prevalence of function‐limiting late effects in survivors of head and neck cancer. PM&R. 2025;17(6):654-662. doi:10.1002/pmrj.13340

BibTeX
@article{Won2025,
  author = {Won, Yu Hui and Stubblefield, Michael D},
  title = {Prevalence of function‐limiting late effects in survivors of head and neck cancer},
  journal = {PM&R},
  year = {2025},
  volume = {17},
  number = {6},
  pages = {654--662},
  doi = {10.1002/pmrj.13340}
}
Kostenlos starten →